Clinical Trial Update: A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy [EARLY_Phase 1]

View source ↗

Summary

A clinical trial entry indicates that Cizutamig is being studied in immunoglobulin A nephropathy and is currently in EARLY Phase 1 with enrollment by invitation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunoglobulin Nephropathy

Drugs mentioned

• Cizutamig

Snippet

Sponsor: Peking University First Hospital | Conditions: Immunoglobulin A Nephropathy (IgAN) | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION